In the context of inflammation and its regulation during myocardial ischemia/reperfusion (MI/R) injury, TLR4 has been identified as a key mediator, with its deficiency shown to significantly reduce MI/R‐induced damage, lipid peroxidation, and complement deposition [58]. This evidence concerns the gene TLR4 and myocardial ischemia.